289 related articles for article (PubMed ID: 16010241)
21. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
[TBL] [Abstract][Full Text] [Related]
22. [New molecular features of cholestatic diseases of the liver].
Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
[TBL] [Abstract][Full Text] [Related]
23. [Bile formation and cholestasis].
Jansen PL; Müller M; Kuipers F
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2384-91. PubMed ID: 11145092
[TBL] [Abstract][Full Text] [Related]
24. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
Claudel T; Zollner G; Wagner M; Trauner M
Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
[TBL] [Abstract][Full Text] [Related]
25. Benign recurrent intrahepatic cholestasis. Evidence for an intrinsic abnormality in hepatocyte secretion.
Minuk GY; Shaffer EA
Gastroenterology; 1987 Dec; 93(6):1187-93. PubMed ID: 3678736
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular bile salt transport: lessons from cholestasis.
Trauner M; Fickert P; Stauber RE
Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
[TBL] [Abstract][Full Text] [Related]
27. [New molecular aspects of cholestatic liver diseases].
Trauner M; Fickert P; Stauber RE
Z Gastroenterol; 1999 Jul; 37(7):639-47. PubMed ID: 10458013
[TBL] [Abstract][Full Text] [Related]
28. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
29. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.
Kamath BM; Stein P; Houwen RHJ; Verkade HJ
Liver Int; 2020 Aug; 40(8):1812-1822. PubMed ID: 32492754
[TBL] [Abstract][Full Text] [Related]
30. The role of inflammation in cholestasis: clinical and basic aspects.
Kosters A; Karpen SJ
Semin Liver Dis; 2010 May; 30(2):186-94. PubMed ID: 20422500
[TBL] [Abstract][Full Text] [Related]
31. Hepatobiliary transport.
Kullak-Ublick GA; Beuers U; Paumgartner G
J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
[TBL] [Abstract][Full Text] [Related]
32. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
33. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
Jansen PL
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
[TBL] [Abstract][Full Text] [Related]
34. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.
Strubbe B; Geerts A; Van Vlierberghe H; Colle I
Acta Gastroenterol Belg; 2012 Dec; 75(4):405-10. PubMed ID: 23402083
[TBL] [Abstract][Full Text] [Related]
35. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
36. [Regulation of hepatobiliary transporters in cholestatic liver disease].
Geier A; Gartung C; Matern S
Med Klin (Munich); 2004 Jan; 99(1):7-17. PubMed ID: 14716480
[TBL] [Abstract][Full Text] [Related]
37. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
39. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
40. Cholestasis: the ABCs of cellular mechanisms for impaired bile secretion--transporters and genes.
Shaffer EA
Can J Gastroenterol; 2002 Jun; 16(6):380-9. PubMed ID: 12096302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
